NO20044868L - Fremgangsmater for behandling av gastrointestinal og genitourinsmerte forstyrrelser ved bruk av vinlafaxin og derivater - Google Patents

Fremgangsmater for behandling av gastrointestinal og genitourinsmerte forstyrrelser ved bruk av vinlafaxin og derivater

Info

Publication number
NO20044868L
NO20044868L NO20044868A NO20044868A NO20044868L NO 20044868 L NO20044868 L NO 20044868L NO 20044868 A NO20044868 A NO 20044868A NO 20044868 A NO20044868 A NO 20044868A NO 20044868 L NO20044868 L NO 20044868L
Authority
NO
Norway
Prior art keywords
gastrointestinal
vinlafaxine
procedures
derivatives
treatment
Prior art date
Application number
NO20044868A
Other languages
English (en)
Inventor
Robyn Gail Karlstadt
Richard Brian Lynn
Michael Scott Burton
Mervyn Danilewitz
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20044868L publication Critical patent/NO20044868L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oppfinnelsen tilveiebringer en fremgangsmåte for behandling av funksjonelle gastrointestinal- og genitourinforstyrrelser hos et pattedyr, ved å administrere til pattedyret en effektiv mengde av hydroksycykloalkan-fenetylamin med strukturformel (1)
NO20044868A 2002-05-17 2004-11-09 Fremgangsmater for behandling av gastrointestinal og genitourinsmerte forstyrrelser ved bruk av vinlafaxin og derivater NO20044868L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38130502P 2002-05-17 2002-05-17
PCT/US2003/015230 WO2003097029A1 (en) 2002-05-17 2003-05-15 Methods of treating gastrointestinal and genitourinary pain disorders using vinlafaxin and derivatives

Publications (1)

Publication Number Publication Date
NO20044868L true NO20044868L (no) 2004-12-08

Family

ID=29550101

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044868A NO20044868L (no) 2002-05-17 2004-11-09 Fremgangsmater for behandling av gastrointestinal og genitourinsmerte forstyrrelser ved bruk av vinlafaxin og derivater

Country Status (21)

Country Link
US (1) US20040019101A1 (no)
EP (1) EP1505960A1 (no)
JP (1) JP2005530779A (no)
KR (1) KR20050003464A (no)
CN (1) CN1652758A (no)
AR (1) AR040033A1 (no)
AU (1) AU2003232137A1 (no)
BR (1) BR0310083A (no)
CA (1) CA2485736A1 (no)
CR (1) CR7568A (no)
EC (1) ECSP045436A (no)
IL (1) IL165216A0 (no)
MX (1) MXPA04011329A (no)
NO (1) NO20044868L (no)
NZ (1) NZ548950A (no)
RU (1) RU2004136999A (no)
SG (1) SG165991A1 (no)
TW (1) TW200402289A (no)
UA (1) UA81413C2 (no)
WO (1) WO2003097029A1 (no)
ZA (1) ZA200410157B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7531543B2 (en) * 2003-10-14 2009-05-12 Wyeth Phenylpiperazine cycloalkanol derivatives and methods of their use
US7365076B2 (en) * 2003-10-14 2008-04-29 Wyeth Substituted aryl cycloalkanol derivatives and methods of their use
US7491723B2 (en) * 2003-10-14 2009-02-17 Wyeth Alkanol and cycloalkanol-amine derivatives and methods of their use
US7550485B2 (en) * 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
US7402698B2 (en) * 2003-10-14 2008-07-22 Wyeth Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
US7419980B2 (en) * 2003-10-14 2008-09-02 Wyeth Fused-aryl and heteroaryl derivatives and methods of their use
US7524846B2 (en) * 2003-10-14 2009-04-28 Wyeth Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
US20070142367A1 (en) * 2003-11-10 2007-06-21 Lundeen James E Method and medicine for treating gastrointestinal disorder including fecal incontinence
US20050113365A1 (en) * 2003-11-10 2005-05-26 Sir Isaac Newton Enterprises Llc Method and medicine for treating gastrointestinal disorder including irritable bowel syndrome
US20060148782A1 (en) * 2003-11-10 2006-07-06 Lundeen James E Method and medicine for treating a mammal presenting urinary incontinence, urinary urgency, or both
US20060148783A1 (en) * 2003-11-10 2006-07-06 Lundeen James E Method and medicine for treating gastrointestinal disorder including fecal incontinence
US20060148781A1 (en) * 2003-11-10 2006-07-06 Lundeen James E Method and medicine for treating gastrointestinal disorder in a non-human mammal
US7820690B2 (en) * 2004-03-19 2010-10-26 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting a non-digestive tract derived abdominal disorder associated with pain using a 5-HT, receptor antagonist
US7517899B2 (en) * 2004-03-30 2009-04-14 Wyeth Phenylaminopropanol derivatives and methods of their use
US7414052B2 (en) * 2004-03-30 2008-08-19 Wyeth Phenylaminopropanol derivatives and methods of their use
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
GB201007032D0 (en) * 2010-04-27 2010-06-09 Dormer Tools Ltd Twist drill for advanced materials
CN102095461B (zh) * 2011-01-18 2012-07-18 姚贤卿 复合型干度质量流量仪及干度标定测量方法
RU2740750C1 (ru) * 2020-03-27 2021-01-20 Аллан Герович Бениашвили Средство для лечения функциональных заболеваний желудочно-кишечного тракта

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
EP0977558B1 (en) * 1996-02-15 2003-10-01 Janssen Pharmaceutica N.V. Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors
US6579899B1 (en) * 1998-07-16 2003-06-17 Massachusetts Institute Of Technology Composition for treatment of stress
US6121259A (en) * 1998-11-23 2000-09-19 Sepracor Inc. Olanzapine-N-oxide compositions and methods
ATE286398T1 (de) * 1998-11-23 2005-01-15 Sepracor Inc Desmethylolanzapine enthaltende zusammensetzungen und verfahren
JP2002530339A (ja) * 1998-11-23 2002-09-17 セプラコール， インク． ２−ヒドロキシメチルオランザピン組成物及び方法
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
GB2355191A (en) * 1999-10-12 2001-04-18 Laxdale Ltd Combination formulations for fatigue, head injury and strokes
WO2003090743A1 (en) * 2002-04-24 2003-11-06 Cypress Bioscience, Inc. Prevention and treatment of functional somatic disorders, including stress-related disorders
MXPA04012347A (es) * 2002-06-10 2005-02-25 Wyeth Corp Nueva sal formiato de o-desmetilvenlafaxina.

Also Published As

Publication number Publication date
TW200402289A (en) 2004-02-16
JP2005530779A (ja) 2005-10-13
CN1652758A (zh) 2005-08-10
EP1505960A1 (en) 2005-02-16
WO2003097029A1 (en) 2003-11-27
SG165991A1 (en) 2010-11-29
ECSP045436A (es) 2005-01-03
CA2485736A1 (en) 2003-11-27
AR040033A1 (es) 2005-03-09
IL165216A0 (en) 2005-12-18
MXPA04011329A (es) 2005-02-14
US20040019101A1 (en) 2004-01-29
BR0310083A (pt) 2005-02-15
AU2003232137A1 (en) 2003-12-02
ZA200410157B (en) 2006-05-31
CR7568A (es) 2005-02-08
NZ548950A (en) 2008-01-31
RU2004136999A (ru) 2006-06-10
KR20050003464A (ko) 2005-01-10
UA81413C2 (en) 2008-01-10

Similar Documents

Publication Publication Date Title
NO20044868L (no) Fremgangsmater for behandling av gastrointestinal og genitourinsmerte forstyrrelser ved bruk av vinlafaxin og derivater
AU5584901A (en) Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease
DK1346041T3 (da) Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
ATE450269T1 (de) Peptid pyyä3-36ü zur behandlung von stoffwechselkrankheiten
HUP0200344A2 (hu) Gabapentinszármazék alkalmazása visceralis fájdalom megelőzésére és kezelésére
BRPI0006634B8 (pt) composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
WO2002002518A3 (en) Compounds to treat alzheimer's disease
WO2002002520A3 (en) Compounds to treat alzheimer's disease
DK1358184T3 (da) N-(3,3-dimethylindolin-6-yl){2-[4-pyridylmethyl)amino](3-pyridyl)}carboxamid samt farmacaceutiske sammensætninger deraf
MXPA04000328A (es) Derivados de alfa-hidroxiamida estatina para tratamiento de enfermedad de alzheimer.
NO20055000L (no) Fremgangsmate for a hindre varme oppblusinger ved anvendelse av prodrug av gaba-analoger
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
MXPA04002785A (es) Aminas sustituidas para tratamiento de enfermedad de alzheimer.
DK1543010T3 (da) N-substituerede hydromorphoner og anvendelse deraf
NO20064974L (no) terapeutiske midler
TW200510311A (en) CCr8 inhibitors
WO2006002096A3 (en) Low doses of l-citrulline for treating diseases
MXPA05004621A (es) Derivados de anilinopirazol utiles en el tratamiento de la diabetes.
ATE390928T1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
IL192287A0 (en) Pharmaceutical compositions and methods for use
SE0400184D0 (sv) New therapeutical use
NO20034301L (no) Cyano-substituerte dihydropyrimidin forbindelser
WO2003070175A3 (en) Use of opioid compound to treat a neurologic or neurogenic disorder
SE0004101D0 (sv) New use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application